更年期荷尔蒙治疗和乳房:临床研究的回顾
Marina Sourouni1, Ludwig Kiesel1
1Department of Gynecology and Obstetrics, University Hospital Münster, Münster, Germany.
Breast care (Basel, Switzerland)
|November 6, 2023
概括
激素替代疗法 (HRT) 具有最小的乳腺癌风险,因持续时间和类型而异. 它通常在乳腺癌后是禁忌的,但在经过仔细的风险评估后,在特定情况下可能会被单独考虑.
科学领域:
- 妇科 妇科 妇科 妇科
- 在瘤学瘤学.
- 更年期管理管理
背景情况:
- 由于卵巢功能下降,更年期症状如热和阴道不适是常见的.
- 激素替代疗法 (HRT) 在缓解症状方面非常有效.
- 人们对HRT与乳腺癌风险的关联存在担忧.
研究的目的:
- 评估HRT的瘤安全性,特别是在乳腺癌风险方面.
- 审查HRT在BRCA携带者和乳腺癌诊断或管道癌 in situ (DCIS) 后的使用.
主要方法:
- 关于HRT使用和乳腺癌风险的选择性文献搜索.
- 对一般人群,BRCA携带者和乳腺癌后患者的研究分析.
主要成果:
- HRT几乎没有增加乳腺癌风险,受HRT持续时间和组成的影响.
- 在停止HRT后,风险会降低.
- 乳腺癌后的瘤安全数据不一致;HRT通常是禁忌的,但可以单独考虑.
结论:
- 在乳腺癌或DCIS之后,HRT通常是禁忌的,需要仔细的风险效益分析进行个人考虑.
- 对于没有乳腺癌史的BRCA携带者,接受风险降低手术的HRT可能会被提供,但如果他们有先前的乳腺癌诊断,则违禁.
相关概念视频
Menopause
174
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
174
Clinical Trials
6.8K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.8K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
133
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
133
Hazard Ratio
136
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
136
Disorders of the Female Reproductive System
373
The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
373
Hormonal Regulation of the Menstrual Cycle
406
The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
406


